Filter posts

JAMA Study Misses the Mark on Cancer R&D Costs & Profitability

Yesterday, JAMA Internal Medicine published a new paper purporting to estimate the R&D expense associated …

Coming this Fall: Arctic Non-browning Apples

In a time of global famine and food insecurity here in the United States, I …

Hepatitis C Has a Cure — Now Insurers Just Need to Pay for It

Today is World Hepatitis Day. In The Hill newspaper, BIO CEO Jim Greenwood argues that …

In New Role, Former UK Prime Minister David Cameron Charts Path ‘Out of Forest’ for Alzheimer's...

Former British Prime Minister David Cameron told attendees at the 2017 BIO International Convention in …

Green Light for CAR-T Leukemia Treatment Is an Historic Moment for Biotechnology

I’ve been President and CEO of BIO for more than a dozen years, and I’ve been …

Former UK Prime Minister David Cameron Zeroes in on Alzheimer’s Research at BIO 2017

Five years ago, during the height of his leadership, then-Prime Minister David Cameron of the …

When Surviving Cancer Hits Close to Home

It has been almost 20 years now, but I’ll never forget the feeling of shock …

Astronaut John Glenn Helped Explore New Frontiers in Osteoporosis Research

One of my favorite stories about medical research involves the late American hero, John Glenn, …

California’s Transparency Bill Misses the Mark

Under a pending bill in California, drug companies would be required to disclose confidential and …

An Earth Day No-Brainer: Use Science To Conquer Famine

Since 1970, we’ve recognized Earth Day every April 22.  The idea came from former Wisconsin …